Misys has issued a statement that it has sufficient funding commitments in place to finance its proposed purchase of shares of Chicago-based Allscripts common stock as part of a series of transactions that includes the merger of Misys Healthcare Systems, LLC (Raleigh, N.C.) with a subsidiary of Allscripts.
According to Misys, it has signed definitive agreements for $325 million of financing to replace its credit facility with Lehman Brothers, and will use the new credit facilities to fund a portion of the consideration for the proposed purchase of shares of common stock of Allscripts.
The new financing will be provided by two sources, says the company: a $150 million revolving credit facility will be provided for a term of 18 months by a lending group comprising HSBC Bank plc, the Governor and Company of the Bank of Ireland, and The Royal Bank of Scotland plc; and the remaining $175 million financing will be provided by ValueAct Capital, Misys’s largest shareholder, under a subordinated credit facility for a term of 20 months.
Misys also confirmed that the $150 million of proceeds from Misys’ equity offering in March 2008, which was underwritten by ValueAct Capital, remains in place.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.